T29-27918-59388 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-26
Dose 1 — Moderna
2022-10-19
Registered in v-safe
2022-10-19
Health check-in — day 21, dose 1, under 3
Feeling: Fair

Under 3 check-in
2022-11-03
Dose 2 — Moderna
Co-administered: Flu
2022-11-03
Health check-in — day 0, dose 2, under 3
Feeling: Good · Sleepiness, Irritability/crying

Under 3 check-in
2022-11-04
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Site: Pain · Sleepiness, Irritability/crying

Under 3 check-in
2022-11-05
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Site: Redness · Fever · Irritability/crying, Diarrhea

Under 3 check-in
2022-11-08
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Sleepiness, Irritability/crying

Under 3 check-in
2022-11-19
Survey response — day 14, dose 2, under 3
MedDRA: Conjunctivitis, Ear infection, Irritability — Feeling: Fair · Be unable to work or attend school

Free text: Double pink eye, ear infection, cold and irritable.

MedDRA releases: 2024-11 · check-in free text available
2022-11-24
Survey response — day 21, dose 2, under 3
MedDRA: Ear infection, Pyrexia, Urticaria — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fever, ear infection, full body hives

MedDRA releases: 2024-11 · check-in free text available
2022-12-01
Survey response — day 28, dose 2, under 3
MedDRA: Conjunctivitis, Cough, Ear infection, Lethargy, Pyrexia, Roseola — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Roseola, pink eye, 104 fever, ear infection, lethargic, and wet cough

MedDRA releases: 2024-11 · check-in free text available
2022-12-01
Report sent to call center — day 28, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-12-02
Call successful
Participant prefers to complete VAERS report online
2022-12-10
Survey response — day 35, dose 2, under 3
MedDRA: Cough — Feeling: Good

Free text: Long cough at night

MedDRA releases: 2024-11 · check-in free text available
2022-12-16
Survey response — day 42, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Good

Free text: Still coughing and runny nose

MedDRA releases: 2024-11 · check-in free text available
2023-02-02
Survey response — 3 months, dose 2, under 3
MedDRA: Pyrexia — Feeling: Poor · Be unable to work or attend school

MedDRA releases: 2024-11
2023-03-15
Dose 3 — Moderna
Co-administered: Hepatitis A:MMR:Pneumonia
2023-03-23
Health check-in — day 7, dose 3, under 3
Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite

Under 3 check-in
2023-04-05
Health check-in — day 21, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-04-12
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-04-19
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-04-26
Health check-in — day 42, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-14
Health check-in — 3 months, dose 3, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-09-26	Moderna	No
2	2022-11-03	Moderna	Flu
3	2023-03-15	Moderna	Hepatitis A:MMR:Pneumonia

Call center

Reported	Outcome	VAERS-related outcome
2022-12-01	Successful 2022-12-02	Participant prefers to complete VAERS report online

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-11-19

Symptoms: Double pink eye, ear infection, cold and irritable.

Release 12 (Under 3) — day 21, dose 2, under 3

2022-11-24

Symptoms: Fever, ear infection, full body hives

Release 12 (Under 3) — day 28, dose 2, under 3

2022-12-01

Symptoms: Roseola, pink eye, 104 fever, ear infection, lethargic, and wet cough

Release 12 (Under 3) — day 35, dose 2, under 3

2022-12-10

Symptoms: Long cough at night

Release 12 (Under 3) — day 42, dose 2, under 3

2022-12-16

Symptoms: Still coughing and runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Ear infection	·	·	✓
SD	Irritability	·	·	✓
SD	Lethargy	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Roseola	·	·	✓
SD	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release